Chapter 4 : Laboratory-Associated Infections

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in

Laboratory-Associated Infections, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555819637/9781555816209.ch4-1.gif /docserver/preview/fulltext/10.1128/9781555819637/9781555816209.ch4-2.gif


Publications on laboratory-associated infections (LAIs) provide critical information for prevention strategies. The review of actual case studies illustrates the importance of adhering to biosafety protocols and may trigger changes in laboratory procedures. Singh has stated that it is time for a centralized system for reporting, analyzing, and communicating “lessons learned” about LAIs to be developed (1). Surveys on some subsets of laboratory workers, and case reports on individual LAIs, have been published; however, without a centralized system, it is impossible to assess the true incidence of LAIs. In addition, the underreporting of such infections is widely acknowledged due to fear of reprisal and the stigma associated with such events (2).

Citation: Byers K, Harding A. 2017. Laboratory-Associated Infections, p 59-92. In Wooley D, Byers K (ed), Biological Safety: Principles and Practices, Fifth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819637.ch4
Highlighted Text: Show | Hide
Loading full text...

Full text loading...


1. Singh K. 2011. It's time for a centralized registry of laboratory-acquired infections. Nat Med 17:919.[CrossRef][PubMed]
2. Sewell DL. 2000. Laboratory-acquired Infections. Clin Microbiol Newsl 22:7377.[CrossRef]
3. Miller JM, Astles R, Baszler T, Chapin K, Carey R, Garcia L, Gray L, Larone D, Pentella M, Pollock A, Shapiro DS, Weirich E, Wiedbrauk D Biosafety Blue Ribbon Panel, Centers for Disease Control and Prevention (CDC). 2012. Guidelines for safe work practices in human and animal medical diagnostic laboratories. Recommendations of a CDC-convened, Biosafety Blue Ribbon Panel. MMWR Suppl 61(Suppl):1102.[PubMed]
4. Trans-Federal Task Force on Optimizing Biosafety and Biocontainment Oversight. 2009. Final report. http://www.ars.usda.gov/is/br/bbotaskforce/biosafety-FINAL-REPORT-092009.pdf.
5. Henckel RD, Miller T, Weyant RS. 2012. Monitoring Select Agent theft, loss, and release reports in the United States—2004–2010. Appl Biosaf 17:171180.[CrossRef]
6. Kimman TG, Smit E, Klein MR. 2008. Evidence-based biosafety: a review of the principles and effectiveness of microbiological containment measures. Clin Microbiol Rev 21:403425.[CrossRef][PubMed]
7. Sulkin SE, Pike RM. 1951. Laboratory-acquired infections. J Am Med Assoc 147:17401745.[CrossRef][PubMed]
8. Reid DD. 1957. Incidence of tuberculosis among workers in medical laboratories. BMJ 2:1014.[CrossRef][PubMed]
9. Phillips GB. 1965a. Microbiological hazards in the laboratory, Part 1. Control. J Chem Educ 42:A43A48.[CrossRef][PubMed]
10. Harrington JM, Shannon HS. 1976. Incidence of tuberculosis, hepatitis, brucellosis, and shigellosis in British medical laboratory workers. BMJ 1:759762.[CrossRef][PubMed]
11. Grist NR. 1981. Infection hazards in clinical laboratories. Scott Med J 26:197198.[PubMed]
12. Grist NR. 1983. Infections in British clinical laboratories 1980–81. J Clin Pathol 36:121126.[CrossRef][PubMed]
13. Jacobson JT, Orlob RB, Clayton JL. 1985. Infections acquired in clinical laboratories in Utah. J Clin Microbiol 21:486489.[PubMed]
14. Vesley D, Hartmann HM. 1988. Laboratory-acquired infections and injuries in clinical laboratories: a 1986 survey. Am J Public Health 78:12131215.[CrossRef][PubMed]
15. Masuda T, Isokawa T. 1991. [Biohazard in clinical laboratories in Japan]. Kansenshogaku Zasshi 65:209215.[CrossRef][PubMed]
16. Baron EJ, Miller JM. 2008. Bacterial and fungal infections among diagnostic laboratory workers: evaluating the risks. Diagn Microbiol Infect Dis 60:241246.[CrossRef][PubMed]
17. Athlin S, Vikerfors T, Fredlund H, Olcén P. 2007. Atypical clinical presentation of laboratory-acquired meningococcal disease. Scand J Infect Dis 39:911913.[CrossRef][PubMed]
18. Riyesh T, Karuppusamy S, Bera BC, Barua S, Virmani N, Yadav S, Vaid RK, Anand T, Bansal M, Malik P, Pahuja I, Singh RK. 2014. Laboratory-acquired buffalopox virus infection, India. Emerg Infect Dis 20:324326.[CrossRef][PubMed]
19. Centers for Disease Control and Prevention. 2011. Multistate Outbreak of Salmonella typhimurium infections associated with exposure to clinical and teaching microbiology laboratories. http://www.cdc.gov/salmonella/typhimurium-laboratory/index.html.
20. Centers for Disease Control and Prevention. 2014. Human Salmonella Typhimurium infections linked to exposure to clinical and teaching microbiology laboratories. http://www.cdc.gov/salmonella/typhimurium-labs-06-14/index.html.
21. Anonymous. 1988. Microbiological safety cabinets and laboratory acquired infection. Lancet 2:844845.[PubMed]
22. Wedum AG, Barkley WE, Hellman A. 1972. Handling of infectious agents. J Am Vet Med Assoc 161:15571567.[PubMed]
23. Sulkin SE, Pike RM. 1951. Survey of laboratory-acquired infections. Am J Public Health Nations Health 41:769781.[CrossRef][PubMed]
24. Pike RM, Sulkin SE. 1952. Occupational hazards in microbiology. Sci Mon 75:222227.
25. Pike RM, Sulkin SE, Schulze ML. 1965. Continuing importance of laboratory-acquired infections. Am J Public Health Nations Health 55:190199.[CrossRef][PubMed]
26. Pike RM. 1976. Laboratory-associated infections: summary and analysis of 3921 cases. Health Lab Sci 13:105114.[PubMed]
27. Pike RM. 1978. Past and present hazards of working with infectious agents. Arch Pathol Lab Med 102:333336.[PubMed]
28. Pike RM. 1979. Laboratory-associated infections: incidence, fatalities, causes, and prevention. Annu Rev Microbiol 33:4166.[CrossRef][PubMed]
29. Shapiro DS, Schwartz DR. 2002. Exposure of laboratory workers to Francisella tularensis despite a bioterrorism procedure. J Clin Microbiol 40:22782281.[CrossRef][PubMed]
30. Centers for Disease Control and Prevention (CDC). 2008. Update: potential exposures to attenuated vaccine strain Brucella abortus RB51 during a laboratory proficiency test—United States and Canada, 2007. MMWR Morb Mortal Wkly Rep 57:3639.[PubMed]
31. Collins CH, Kennedy DA. 1999. Laboratory-Acquired Infections: History, Incidence, Causes and Preventions, 4th ed. Butterworth Heinemann, Oxford.
32. Brener Z. 1987. Laboratory-acquired Chagas disease: comment. Trans R Soc Trop Med Hyg 81:527.[CrossRef][PubMed]
33. Walker D, Campbell D. 1999. A survey of infections in United Kingdom laboratories, 1994–1995. J Clin Pathol 52:415418.[CrossRef][PubMed]
34. Willemark N, Van Vaerenbergh B, Descamps E, Brosius B, Dai Do Thi C, Leunda A, Baldo A, Herman P. 2015. Laboratory-Acquired Infections in Belgium (2007–2012). Institut Scientifique de Santé Publique, Brussels, Belgium. http://www.biosafety.be/CU/PDF/2015_Willemarck_LAI%20report%20Belgium_2007_2012_Final.pdf.
35. Boutet R, Stuart JM, Kaczmarski EB, Gray SJ, Jones DM, Andrews N. 2001. Risk of laboratory-acquired meningococcal disease. J Hosp Infect 49:282284.[CrossRef][PubMed]
36. Bremner DA. 1992. Laboratory acquired meningococcal septicaemia. Aust Microbiol 13:A106.
37. Centers for Disease Control (CDC). 1991. Laboratory-acquired meningococcemia—California and Massachusetts. MMWR Morb Mortal Wkly Rep 40:4647, 55.[PubMed]
38. Centers for Disease Control and Prevention (CDC). 2002. Laboratory-acquired meningococcal disease—United States, 2000. MMWR Morb Mortal Wkly Rep 51:141144.[PubMed]
39. Sheets CD, Harriman K, Zipprich J, Louie JK, Probert WS, Horowitz M, Prudhomme JC, Gold D, Mayer L. 2014. Fatal meningococcal disease in a laboratory worker—California, 2012. MMWR Morb Mortal Wkly Rep 63:770772.[PubMed]
40. Paradis JF, Grimard D. 1994. Laboratory-acquired invasive meningococcus—Quebec. Can Commun Dis Rep 20:1214.[PubMed]
41. Sejvar JJ, Johnson D, Popovic T, Miller JM, Downes F, Somsel P, Weyant R, Stephens DS, Perkins BA, Rosenstein NE. 2005. Assessing the risk of laboratory-acquired meningococcal disease. J Clin Microbiol 43:48114814.[CrossRef][PubMed]
42. Al-Aska AK, Chagla AH. 1989. Laboratory-acquired brucellosis. J Hosp Infect 14:6971.[CrossRef][PubMed]
43. Georghiou PR, Young EJ. 1991. Prolonged incubation in brucellosis. Lancet 337:1543.[CrossRef][PubMed]
44. Young EJ. 1983. Human brucellosis. Rev Infect Dis 5:821842.[CrossRef][PubMed]
45. Young EJ. 1991. Serologic diagnosis of human brucellosis: analysis of 214 cases by agglutination tests and review of the literature. Rev Infect Dis 13:359372.[CrossRef][PubMed]
46. Blaser MJ, Hickman FW, Farmer JJ III,. Brenner DJ, Balows A, Feldman RA. 1980. Salmonella typhi: the laboratory as a reservoir of infection. J Infect Dis 142:934938.[CrossRef][PubMed]
47. Blaser MJ, Lofgren JP. 1981. Fatal salmonellosis originating in a clinical microbiology laboratory. J Clin Microbiol 13:855858.[PubMed]
48. Centers for Disease Control and Prevention (CDC). 2011. Fatal laboratory-acquired infection with an attenuated Yersinia pestis strain—Chicago, Illinois, 2009. MMWR Morb Mortal Wkly Rep 60:201205.[PubMed]
49. Wong D, Wild MA, Walburger MA, Higgins CL, Callahan M, Czarnecki LA, Lawaczeck EW, Levy CE, Patterson JG, Sunenshine R, Adem P, Paddock CD, Zaki SR, Petersen JM, Schriefer ME, Eisen RJ, Gage KL, Griffith KS, Weber IB, Spraker TR, Mead PS. 2009. Primary pneumonic plague contracted from a mountain lion carcass. Clin Infect Dis 49:e33e38.[CrossRef][PubMed]
50. De Schrijver KAL,. Bertrand S, Collard JM, Eilers K,. De Schrijver K, Lemmens A, Bertrand S, Collard JM, Eilers K. 2007. [Een laboratoriuminfectie met Shigella sonnei gevolgd door een cluster secundaire infectiessecundaire infecties] Abstract in English: Outbreak of Shigella sonnei in a clinical microbiology laboratory with secondary infections in the community). Tijdschr Geneeskd 63:686690.[CrossRef]
51. Ruben B, Band JD, Wong P, Colville J. 1991. Person-to-person transmission of Brucella melitensis. Lancet 337:1415.[CrossRef][PubMed]
52. Goossens H, Marcelis L, Dekeyser P, Butzler JP. 1983. Brucella melitensis: person-to-person transmission? Lancet 321:773[CrossRef].[PubMed]
53. Bolin CA, Koellner P. 1988. Human-to-human transmission of Leptospira interrogans by milk. J Infect Dis 158:246247.[CrossRef][PubMed]
54. U.S. Department of Health and Human Services Public Health Service. 1999. Biosafety in Microbiological and Biomedical Laboratories. Centers for Disease Control and Prevention and National Institutes of Health te. U.S. Government Printiing Office, Washington, D.C.
55. Jager MM, Murk JL, Pique R, Wulf MW, Leenders AC, Buiting AG, Bogaards JA, Kluytmans JA, Vandenbroucke-Grauls CM. 2010. Prevalence of carriage of meticillin-susceptible and meticillin-resistant Staphylococcus aureus in employees of five microbiology laboratories in The Netherlands. J Hosp Infect 74:292294.[CrossRef][PubMed]
56. Centers for Disease Control and Prevention (CDC). 2008. Laboratory-acquired brucellosis—Indiana and Minnesota, 2006. MMWR Morb Mortal Wkly Rep 57:3942.[PubMed]
57. Batchelor BI, Brindle RJ, Gilks GF, Selkon JB. 1992. Biochemical mis-identification of Brucella melitensis and subsequent laboratory-acquired infections. J Hosp Infect 22:159162.[CrossRef][PubMed]
58. Fiori PL, Mastrandrea S, Rappelli P, Cappuccinelli P. 2000. Brucella abortus infection acquired in microbiology laboratories. J Clin Microbiol 38:20052006.[PubMed]
59. Gerberding JL, Romero JM, Ferraro MJ. 2008. Case 34-2008. A 58-year-old woman with neck pain and fever. N Engl J Med 359:19421949.[CrossRef][PubMed]
60. Ollé-Goig JE, Canela-Soler J. 1987. An outbreak of Brucella melitensis infection by airborne transmission among laboratory workers. Am J Public Health 77:335338.[CrossRef][PubMed]
61. Staszkiewicz J, Lewis CM, Colville J, Zervos M, Band J. 1991. Outbreak of Brucella melitensis among microbiology laboratory workers in a community hospital. J Clin Microbiol 29:287290.[PubMed]
62. Ozaras R, Celik AD, Demirel A. 2004. Acute hepatitis due to brucellosis in a laboratory technician. Eur J Intern Med 15:264.[CrossRef][PubMed]
63. Emrys G. 2008. Report into the investigation of ESR meningitis infection case of Dr. Jeannette Adu-Bobie. http://www.dol.govt.nz/news/media/2008/adu-bobie-report.asp.
64. Burnens AP, Zbinden R, Kaempf L, Heinzer I, Nicolet J. 1993. A case of laboratory acquired infection with Escherichia coli O157:H7. Zentralbl Bakteriol 279:512517.[CrossRef][PubMed]
65. Olesen B, Jensen C, Olsen K, Fussing V, Gerner-Smidt P, Scheutz F. 2005. VTEC O117:K1:H7. A new clonal group of E. coli associated with persistent diarrhoea in Danish travellers. Scand J Infect Dis 37:288294.[CrossRef][PubMed]
66. Spina N, Zansky S, Dumas N, Kondracki S. 2005. Four laboratory-associated cases of infection with Escherichia coli O157:H7. J Clin Microbiol 43:29382939.[CrossRef][PubMed]
67. Thilo W, Kiehl W, Geiss HK. 1997. A case report of laboratory-acquired diphtheria. Euro Surveill 2:6768.[PubMed]
68. Laboratory PHS. 1998. Throat infection with toxigenic Corynebacterium diptheriae. Commun Dis Wkly Rep 8:6061.
69. Yanyu L. 2011. Dean, secretary deposed after group infection. http://www.chinadaily.com.cn/china/2011-09/04/content_13614791.htm
70. Said SS M.A., Wright-Andoh J., Myers R., Razeq J, Blythe D.. 2011. Salmonella enterica serotype Typhimurium gastrointestinal illness associated with a university microbiology course—Maryland, abstr. 62nd Epidemic Intelligence Service (EIS) Conference. 62: 03.
71. Centers for Disease Control and Prevention (CDC). 2013. Salmonella typhimurium infections associated with a community college microbiology laboratory—Maine, 2013. MMWR Morb Mortal Wkly Rep 62:863.[PubMed]
72. Steckelberg JM, Terrell CL, Edson RS. 1988. Laboratory-acquired Salmonella typhimurium enteritis: association with erythema nodosum and reactive arthritis. Am J Med 85:705707.[CrossRef][PubMed]
73. Hoerl D, Rostkowski C, Ross SL, Walsh TJ. 1988. Typhoid fever acquired in a medical teaching laboratory. Lab Med 19:166168.[CrossRef]
74. Centers for Disease Control (CDC). 1984. Rat-bite fever in a college student—California. MMWR Morb Mortal Wkly Rep 33:318320.[PubMed]
75. Montes J, Rodriguez MA, Martin T, Martin F. 1986. Laboratory-acquired meningitis caused by Brucella abortus strain 19. J Infect Dis 154:915916.[CrossRef][PubMed]
76. Wallach JC, Ferrero MC, Victoria Delpino M, Fossati CA, Baldi PC. 2008. Occupational infection due to Brucella abortus S19 among workers involved in vaccine production in Argentina. Clin Microbiol Infect 14:805807.[CrossRef][PubMed]
77. Centers for Disease Control and Prevention (CDC). 2007. Salmonella serotype enteritidis infections among workers producing poultry vaccine—Maine, November-December 2006. MMWR Morb Mortal Wkly Rep 56:877879.[PubMed]
78. Schlech WF III,. Turchik JB, Westlake RE Jr,. Klein GC, Band JD, Weaver RE. 1981. Laboratory-acquired infection with Pseudomonas pseudomallei (melioidosis). N Engl J Med 305:11331135.[CrossRef][PubMed]
79. Meselson M, Guillemin J, Hugh-Jones M, Langmuir A, Popova I, Shelokov A, Yampolskaya O. 1994. The Sverdlovsk anthrax outbreak of 1979. Science 266:12021208.[CrossRef][PubMed]
80. Bhatti AR, DiNinno VL, Ashton FE, White LA. 1982. A laboratory-acquired infection with Neisseria meningitidis. J Infect 4:247252.[CrossRef][PubMed]
81. Kessler AT, Stephens DS, Somani J. 2007. Laboratory-acquired serogroup A meningococcal meningitis. J Occup Health 49:399401.[CrossRef][PubMed]
82. New Zealand Herald. 2005. Scientist loses limbs to meningococcal disease. http://www.nzherald.co.nz/nz/news/article.cfm?c_id=1&objectid=10120376.
83. Omer H, Rose G, Jolley KA, Frapy E, Zahar JR, Maiden MC, Bentley SD, Tinsley CR, Nassif X, Bille E. 2011. Genotypic and phenotypic modifications of Neisseria meningitidis after an accidental human passage. PLoS One 6:e17145.[CrossRef][PubMed]
84. ProMED-mail. 2009. Meningitis, meningococcal, USA (Massachusetts). http://www.promedmail.org/post/20091112.3924.
85. Centers for Disease Control and Prevention (CDC). 2011. Fatal laboratory-acquired infection with an attenuated Yersinia pestis Strain—Chicago, Illinois, 2009. MMWR Morb Mortal Wkly Rep 60:201205.[PubMed]
86. Barry M. 2005. Report of pneumonic tularemia in three Boston University researchers—November 2004–March 2005. Boston Public Health Commission, Boston, MA. http://cbc.arizona.edu/sites/default/files/Boston_Univerity_Tularemia_report_2005.pdf
87. Eckstein M. 2010. Army-broken procedures led to lab infection. http://www.fredericknewspost.com/archive/article_5e4539ea-7902-5b13-8d37-8c7b6ade7538.html.
88. Rusnak J, Boudreau E, Bozue J, Petitt P, Ranadive M, Kortepeter M. 2004. An unusual inhalational exposure to Bacillus anthracis in a research laboratory. J Occup Environ Med 46:313314.[CrossRef][PubMed]
89. Bouza E, Martin A, Van den Berg RJ, Kuijper EJ. 2008. Laboratory-acquired clostridium difficile polymerase chain reaction ribotype 027: a new risk for laboratory workers? Clin Infect Dis 47:14931494.[CrossRef][PubMed]
90. Lavelle JP, Landas S., Mitros F, Conklin JL. 1994. Acute gastritis associated with spiral organisms from cats. Dig Dis Sci 39:744750.
91. Huhulescu S, Leitner E, Feierl G, Allerberger F. 2010. Laboratory-acquired Vibrio cholerae O1 infection in Austria, 2008. Clin Microbiol Infect 16:13031304.[CrossRef][PubMed]
92. Barkham T, Taylor MB. 2002. Sniffing bacterial cultures on agar plates: a useful tool or a safety hazard? J Clin Microbiol 40:3877.[CrossRef][PubMed]
93. Miller CD, Songer JR, Sullivan JF. 1987. A twenty-five year review of laboratory-acquired human infections at the National Animal Disease Center. Am Ind Hyg Assoc J 48:271275.[CrossRef][PubMed]
94. Yagupsky P, Peled N, Riesenberg K, Banai M. 2000. Exposure of hospital personnel to Brucella melitensis and occurrence of laboratory-acquired disease in an endemic area. Scand J Infect Dis 32:3135.[CrossRef][PubMed]
95. Centers for Disease Control and Prevention (CDC). 2008. Laboratory-acquired brucellosis—Indiana and Minnesota, 2006. MMWR Morb Mortal Wkly Rep 57:3942.[PubMed]
96. Shemesh AA, Yagupsky P. 2012. Isolation rates of Brucella melitensis in an endemic area and implications for laboratory safety. Eur J Clin Microbiol Infect Dis 31:441443.[CrossRef][PubMed]
97. Kiel FW, Khan MY. 1993. Brucellosis among hospital employees in Saudi Arabia. Infect Control Hosp Epidemiol 14:268272.[CrossRef][PubMed]
98. Ergönül O, Celikbaş A, Tezeren D, Güvener E, Dokuzoğuz B. 2004. Analysis of risk factors for laboratory-acquired brucella infections. J Hosp Infect 56:223227.[CrossRef][PubMed]
99. Hasanjani Roushan MR, Mohrez M, Smailnejad Gangi SM, Soleimani Amiri MJ, Hajiahmadi M. 2004. Epidemiological features and clinical manifestations in 469 adult patients with brucellosis in Babol, Northern Iran. Epidemiol Infect 132:11091114.[CrossRef][PubMed]
100. Eales KM, Norton RE, Ketheesan N. 2010. Brucellosis in northern Australia. Am J Trop Med Hyg 83:876878.[CrossRef][PubMed]
101. Jiang H, Fan M, Chen J, Mi J, Yu R, Zhao H, Piao D, Ke C, Deng X, Tian G, Cui B. 2011. MLVA genotyping of Chinese human Brucella melitensis biovar 1, 2 and 3 isolates. BMC Microbiol 11:256.[CrossRef][PubMed]
102. Al Dahouk S, Neubauer H, Hensel A, Schöneberg I, Nöckler K, Alpers K, Merzenich H, Stark K, Jansen A. 2007. Changing epidemiology of human brucellosis, Germany, 1962–2005. Emerg Infect Dis 13:18951900.[CrossRef][PubMed]
103. Grammont-Cupillard M, Berthet-Badetti L, Dellamonica P. 1996. Brucellosis from sniffing bacteriological cultures. Lancet 348:17331734.[CrossRef][PubMed]
104. Demirdal T, Demirturk N. 2008. Laboratory-acquired brucellosis. Ann Acad Med Singapore 37:8687.[PubMed]
105. Memish ZA, Alazzawi M, Bannatyne R. 2001. Unusual complication of breast implants: brucella infection. Infection 29:291292.[CrossRef][PubMed]
106. Memish ZA, Venkatesh S. 2001. Brucellar epididymo-orchitis in Saudi Arabia: a retrospective study of 26 cases and review of the literature. BJU Int 88:7276.[CrossRef][PubMed]
107. Memish ZA, Mah MW. 2001. Brucellosis in laboratory workers at a Saudi Arabian hospital. Am J Infect Control 29:4852.[CrossRef][PubMed]
108. Aloufi AD, Memish ZA, Assiri AM, McNabb SJN. 2016. Trends of reported human cases of brucellosis, Kingdom of Saudi Arabia, 2004–2012. J Epidemiol Glob Health 6:1118.[CrossRef][PubMed]
109. Robichaud S, Libman M, Behr M, Rubin E. 2004. Prevention of laboratory-acquired brucellosis. Clin Infect Dis 38:e119e122.[CrossRef][PubMed]
110. Chusid MJ, Russler SK, Mohr BA, Margolis DA, Hillery CA, Kehl KC. 1993. Unsuspected brucellosis diagnosed in a child as a result of an outbreak of laboratory-acquired brucellosis. Pediatr Infect Dis J 12:10311033.[CrossRef][PubMed]
111. Peiris V, Fraser S, Fairhurst M, Weston D, Kaczmarski E. 1992. Laboratory diagnosis of brucella infection: some pitfalls. Lancet 339:14151416.[CrossRef][PubMed]
112. Public Health Service Laboratory. 1991. Microbiological test strip (API20NE) identifies Brucella melitensis as Moraxella phenylpyruvica. CDR (Lond Engl Wkly) 1:165.[PubMed]
113. Noviello S, Gallo R, Kelly M, Limberger RJ, DeAngelis K, Cain L, Wallace B, Dumas N. 2004. Laboratory-acquired brucellosis. Emerg Infect Dis 10:18481850.[CrossRef][PubMed]
114. Gruner E, Bernasconi E, Galeazzi RL, Buhl D, Heinzle R, Nadal D. 1994. Brucellosis: an occupational hazard for medical laboratory personnel. Report of five cases. Infection 22:3336.[CrossRef][PubMed]
115. Luzzi GA, Brindle R, Sockett PN, Solera J, Klenerman P, Warrell DA. 1993. Brucellosis: imported and laboratory-acquired cases, and an overview of treatment trials. Trans R Soc Trop Med Hyg 87:138141.[CrossRef][PubMed]
116. Bouza E, Sánchez-Carrillo C, Hernangómez S, González MJ The Spanish Co-operative Group for the Study of Laboratory-acquired Brucellosis. 2005. Laboratory-acquired brucellosis: a Spanish national survey. J Hosp Infect 61:8083.[CrossRef][PubMed]
117. Schulze zur Wiesch J, Wichmann D, Sobottka I, Rohde H, Schmoock G, Wernery R, Schmiedel S, Dieter Burchard G, Melzer F. 2010. Genomic tandem repeat analysis proves laboratory-acquired brucellosis in veterinary (camel) diagnostic laboratory in the United Arab Emirates. Zoonoses Public Health 57:315317.[PubMed]
118. Hartady T, Saad MZ, Bejo SK, Salisi MS. 2014. Clinical human brucellosis in Malaysia: a case report. Asian Pac J Trop Dis 4:150153.[CrossRef]
119. Traxler RM, Lehman MW, Bosserman EA, Guerra MA, Smith TL. 2013. A literature review of laboratory-acquired brucellosis. J Clin Microbiol 51:30553062.[CrossRef][PubMed]
120. Traxler RM, Guerra MA, Morrow MG, Haupt T, Morrison J, Saah JR, Smith CG, Williams C, Fleischauer AT, Lee PA, Stanek D, Trevino-Garrison I, Franklin P, Oakes P, Hand S, Shadomy SV, Blaney DD, Lehman MW, Benoit TJ, Stoddard RA, Tiller RV, De BK, Bower W, Smith TL. 2013. Review of brucellosis cases from laboratory exposures in the United States in 2008 to 2011 and improved strategies for disease prevention. J Clin Microbiol 51:31323136.[CrossRef][PubMed]
121. United States Government Accountability Office. 2009. High-containment laboratories national strategy for oversight is needed. GAO-09-1045T. http://www.gao.gov/new.items/d09574.pdf.
122. Brew SD, Perrett LL, Stack JA, MacMillan AP, Staunton NJ. 1999. Human exposure to Brucella recovered from a sea mammal. Vet Rec 144:483.[PubMed]
123. Wallach JC, Giambartolomei GH, Baldi PC, Fossati CA. 2004. Human infection with M-strain of Brucella canis. Emerg Infect Dis 10:146148.[CrossRef][PubMed]
124. Arlett PR. 1996. A case of laboratory acquired brucellosis. BMJ 313:11301132.[CrossRef][PubMed]
125. Shireman PK. 1992. Endometrial tuberculosis acquired by a health care worker in a clinical laboratory. Arch Pathol Lab Med 116:521523.[PubMed]
126. Müller HE. 1988. Laboratory-acquired mycobacterial infection. Lancet 332:331.[CrossRef][PubMed]
127. Clark RP, Rueda-Pedraza ME, Teel LD, Salkin IF, Mahoney W. 1988. Microbiological safety cabinets and laboratory acquired infection. Lancet 332:844845.[CrossRef][PubMed]
128. Goto M, Yamashita T, Misawa S, Komori T, Okuzumi K, Takahashi T. 2007. [Current biosafety in clinical laboratories in Japan: report of questionnaires’ data obtained from clinical laboratory personnel in Japan]. Kansenshogaku Zasshi 81:3944.[CrossRef][PubMed]
129. Centers for Disease Control (CDC). 1981. Tuberculous infection associated with tissue processing—California. MMWR Morb Mortal Wkly Rep 30:7374.[PubMed]
130. Grist NR, Emslie J. 1985. Infections in British clinical laboratories, 1982–3. J Clin Pathol 38:721725.[CrossRef][PubMed]
131. Grist NR, Emslie JA. 1987. Infections in British clinical laboratories, 1984–5. J Clin Pathol 40:826829.[CrossRef][PubMed]
132. Grist NR, Emslie JA. 1989. Infections in British clinical laboratories, 1986–87. J Clin Pathol 42:677681.[CrossRef][PubMed]
133. Menzies D, Fanning A, Yuan L, FitzGerald JM Canadian Collaborative Group in Nosocomial Transmission of Tuberculosis. 2003. Factors associated with tuberculin conversion in Canadian microbiology and pathology workers. Am J Respir Crit Care Med 167:599602.[CrossRef][PubMed]
134. Posthaus H, Bodmer T, Alves L, Oevermann A, Schiller I, Rhodes SG, Zimmerli S. 2011. Accidental infection of veterinary personnel with Mycobacterium tuberculosis at necropsy: a case study. Vet Microbiol 149:374380.[CrossRef][PubMed]
135. Templeton GL, Illing LA, Young L, Cave D, Stead WW, Bates JH. 1995. The risk for transmission of Mycobacterium tuberculosis at the bedside and during autopsy. Ann Intern Med 122:922925.[CrossRef][PubMed]
136. Peerbooms PGH, van Doornum GJJ, van Deutekom H, Coutinho RA, van Soolingen D. 1995. Laboratory-acquired tuberculosis. Lancet 345:13111312.[CrossRef][PubMed]
137. Bemer-Melchior P, Drugeon HB. 1999. Inactivation of Mycobacterium tuberculosis for DNA typing analysis. J Clin Microbiol 37:23502351.[PubMed]
138. Angela M, Weber YB, Mortimer VD. 2000. A tuberculosis outbreak among medical waste workers. J Am Biol Saf Assoc 5:7080.
139. Kao AS, Ashford DA, McNeil MM, Warren NG, Good RC. 1997. Descriptive profile of tuberculin skin testing programs and laboratory-acquired tuberculosis infections in public health laboratories. J Clin Microbiol 35:18471851.[PubMed]
140. Belchior I, Seabra B, Duarte R. 2011. Primary inoculation skin tuberculosis by accidental needle stick. BMJ Case Rep 2011:bcr1120103496.[CrossRef][PubMed]
141. Washington State Department of Labor and Industries Region 2—Seattle Office. 2004. Inspection report on laboratory associated infections due to Mycobacterium tuberculosis. Inspection307855056. http://www.sunshine-project.org/idriuwmadchamber.pdf.
142. Bernstein DI, Hubbard T, Wenman WM, Johnson BL Jr,. Holmes KK, Liebhaber H, Schachter J, Barnes R, Lovett MA. 1984. Mediastinal and supraclavicular lymphadenitis and pneumonitis due to Chlamydia trachomatis serovars L1 and L2. N Engl J Med 311:15431546.[CrossRef][PubMed]
143. Paran H, Heimer D, Sarov I. 1986. Serological, clinical and radiological findings in adults with bronchopulmonary infections caused by Chlamydia trachomatis. Isr J Med Sci 22:823827.[PubMed]
144. Marr JJ. 1983. The professor and the pigeon. Psittacosis in the groves of academe. Mo Med 80:135136.[PubMed]
145. Van Droogenbroeck C, Beeckman DS, Verminnen K, Marien M, Nauwynck H, Boesinghe LT, Vanrompay D. 2009. Simultaneous zoonotic transmission of Chlamydophila psittaci genotypes D, F and E/B to a veterinary scientist. Vet Microbiol 135:7881.[CrossRef][PubMed]
146. Olson LD. 1980. Accidental penetration of hands with virulent and avirulent Pasteurella multocida of turkey origin. Avian Dis 24:10641066.[CrossRef][PubMed]
147. Janier M, Gheorghiu M, Cohen P, Mazas F, Duroux P. 1982. [Carpal tunnel syndrome due to mycobacterium bovis BCG (author's transl)]. Sem Hop 58:977979.[PubMed]
148. Salerno AE, Meyers KE, McGowan KL, Kaplan BS. 2004. Hemolytic uremic syndrome in a child with laboratory-acquired Escherichia coli O157:H7. J Pediatr 145:412414.[CrossRef][PubMed]
149. Blaser MJ, Feldman RA. 1980. Acquisition of typhoid fever from proficiency-testing specimens. N Engl J Med 303:1481.[CrossRef][PubMed]
150. Mermel LA, Josephson SL, Dempsey J, Parenteau S, Perry C, Magill N. 1997. Outbreak of Shigella sonnei in a clinical microbiology laboratory. J Clin Microbiol 35:31633165.[PubMed]
151. Bavoil PM. 2005. Federal indifference to laboratory-acquired infections. ASM News 71:1. (Letter.)
152. Rangel JM, Sparling PH, Crowe C, Griffin PM, Swerdlow DL. 2005. Epidemiology of Escherichia coli O157:H7 outbreaks, United States, 1982–2002. Emerg Infect Dis 11:603609.[CrossRef][PubMed]
153. Kozlovac J, Gurtler J. 2015. E. coli 0157:H7 case study. Abstr. USDA ARS 3rd International Biosafety & Biocontainment Symposium: Biorisk Management in a One-Health World, Baltimore, MD.
154. Vraneš J, Lukšić I, Knežević J, Ljubin-Sternak S. 2015. Health care associated cutaneous abscess—a rare form of primary gonococcal infection. Am J Med Case Rep 3:8890.[CrossRef]
155. Centers for Disease Control and Prevention (CDC). 2002. Update: cutaneous anthrax in a laboratory worker—Texas, 2002. MMWR Morb Mortal Wkly Rep 51:482.[PubMed]
156. Bhatia VN. 1990. Possible multiplication of M. leprae (?) on skin and nail bed of a laboratory worker. Indian J Lepr 62:226227.[PubMed]
157. Welsh HH, Lennette EH, Abinanti FR, Winn JF. 1951. Q fever in California. IV. Occurrence of Coxiella burnetii in the placenta of naturally infected sheep. Public Health Rep 66:14731477.[CrossRef][PubMed]
158. Weigler BJ, Di Giacomo RF, Alexander S. 2005. A national survey of laboratory animal workers concerning occupational risks for zoonotic diseases. Comp Med 55:183191.[PubMed]
159. Ossewaarde JM, Hekker AC. 1984. [Q fever infection probably caused by a human placenta]. Ned Tijdschr Geneeskd 128:22582260.[PubMed]
160. Rusnak JM, Kortepeter MG, Aldis J, Boudreau E. 2004. Experience in the medical management of potential laboratory exposures to agents of bioterrorism on the basis of risk assessment at the United States Army Medical Research Institute of Infectious Diseases (USAMRIID). J Occup Environ Med 46:801811.[CrossRef][PubMed]
161. Halle S, Dasch GA. 1980. Use of a sensitive microplate enzyme-linked immunosorbent assay in a retrospective serological analysis of a laboratory population at risk to infection with typhus group rickettsiae. J Clin Microbiol 12:343350.[PubMed]
162. Perna A, Di Rosa S, Intonazzo V, Sferlazzo A, Tringali G, La Rosa G. 1990. Epidemiology of boutonneuse fever in western Sicily: accidental laboratory infection with a rickettsial agent isolated from a tick. Microbiologica 13:253256.[PubMed]
163. Norazah A, Mazlah A, Cheong YM, Kamel AG. 1995. Laboratory acquired murine typhus—a case report. Med J Malaysia 50:177179.[PubMed]
164. Oh M, Kim N, Huh M, Choi C, Lee E, Kim I, Choe K. 2001. Scrub typhus pneumonitis acquired through the respiratory tract in a laboratory worker. Infection 29:5456.[CrossRef][PubMed]
165. Woo JH, Cho JY, Kim YS, Choi DH, Lee NM, Choe KW, Chang WH. 1990. A case of laboratory-acquired murine typhus. Korean J Intern Med 5:118122.[CrossRef][PubMed]
166. Israeli E. 2014. [A hantavirus killed an Israeli researcher: hazards while working with wild animals]. Harefuah 153:443444, 499.[PubMed]
167. Sinclair JR, Carroll DS, Montgomery JM, Pavlin B, McCombs K, Mills JN, Comer JA, Ksiazek TG, Rollin PE, Nichol ST, Sanchez AJ, Hutson CL, Bell M, Rooney JA. 2007. Two cases of hantavirus pulmonary syndrome in Randolph County, West Virginia: a coincidence of time and place? Am J Trop Med Hyg 76:438442.[PubMed]
168. Gire SK. , et al. 2014. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science 345:13691372.[CrossRef][PubMed]
169. Koebler J. 2016. Five scientists died of Ebola while working on a single study of the virus., Update 9/3/14. Motherboard. http://motherboard.vice.com/read/five-scientists-died-of-ebola-while-working-on-a-single-study-on-the-virus.
170. Mulders MN, Reimerink JH, Koopmans MP, van Loon AM, van der Avoort HG. 1997. Genetic analysis of wild-type poliovirus importation into The Netherlands (1979–1995). J Infect Dis 176:617624.[CrossRef][PubMed]
171. Foy BD, Kobylinski KC, Chilson Foy JL, Blitvich BJ, Travassos da Rosa A, Haddow AD, Lanciotti RS, Tesh RB. 2011. Probable non-vector-borne transmission of Zika virus, Colorado, USA. Emerg Infect Dis 17:880882.[CrossRef][PubMed]
172. Chen EC, Yagi S, Kelly KR, Mendoza SP, Maninger N, Rosenthal A, Spinner A, Bales KL, Schnurr DP, Lerche NW, Chiu CY. 2011. Cross-species transmission of a novel adenovirus associated with a fulminant pneumonia outbreak in a new world monkey colony. PLoS Pathog 7:e1002155.[CrossRef][PubMed]
173. Heymann DL, Aylward RB, Wolff C. 2004. Dangerous pathogens in the laboratory: from smallpox to today's SARS setbacks and tomorrow's polio-free world. Lancet 363:15661568.[CrossRef][PubMed]
174. Joyce MP, Kuhar D, Brooks JT. 2015. Notes from the field: occupationally acquired HIV infection among health care workers—United States, 1985–2013. MMWR Morb Mortal Wkly Rep 63:12451246.[PubMed]
175. Ippolito G, Puro V, Heptonstall J, Jagger J, De Carli G, Petrosillo N. 1999. Occupational human immunodeficiency virus infection in health care workers: worldwide cases through September 1997. Clin Infect Dis 28:365383.[CrossRef][PubMed]
176. Eberle J, Habermann J, Gürtler LG. 2000. HIV-1 infection transmitted by serum droplets into the eye: a case report. AIDS 14:206207.[CrossRef][PubMed]
177. Centers for Disease Control (CDC). 1992. Seroconversion to simian immunodeficiency virus in two laboratory workers. MMWR Morb Mortal Wkly Rep 41:678681.[PubMed]
178. Centers for Disease Control and Prevention (CDC). 2008. Laboratory-acquired vaccinia exposures and infections—United States, 2005–2007. MMWR Morb Mortal Wkly Rep 57:401404.[PubMed]
179. Hsu CH, Farland J, Winters T, Gunn J, Caron D, Evans J, Osadebe L, Bethune L, McCollum AM, Patel N, Wilkins K, Davidson W, Petersen B, Barry MA Centers for Disease Control and Prevention (CDC). 2015. Laboratory-acquired vaccinia virus infection in a recently immunized person—Massachusetts, 2013. MMWR Morb Mortal Wkly Rep 64:435438.[PubMed]
180. Jones L, Ristow S, Yilma T, Moss B. 1986. Accidental human vaccination with vaccinia virus expressing nucleoprotein gene. Nature 319:543.[CrossRef][PubMed]
181. Mempel M, Isa G, Klugbauer N, Meyer H, Wildi G, Ring J, Hofmann F, Hofmann H. 2003. Laboratory acquired infection with recombinant vaccinia virus containing an immunomodulating construct. J Invest Dermatol 120:356358.[CrossRef][PubMed]
182. Openshaw PJ, Alwan WH, Cherrie AH, Record FM. 1991. Accidental infection of laboratory worker with recombinant vaccinia virus. Lancet 338:459.[CrossRef][PubMed]
183. MacNeil A, Reynolds MG, Damon IK. 2009. Risks associated with vaccinia virus in the laboratory. Virology 385:14.[CrossRef][PubMed]
184. Rocke TE, Dein FJ, Fuchsberger M, Fox BC, Stinchcomb DT, Osorio JE. 2004. Limited infection upon human exposure to a recombinant raccoon pox vaccine vector. Vaccine 22:27572760.[CrossRef][PubMed]
185. Eisenbach C, Neumann-Haefelin C, Freyse A, Korsukéwitz T, Hoyler B, Stremmel W, Thimme R, Encke J. 2007. Immune responses against HCV-NS3 after accidental infection with HCV-NS3 recombinant vaccinia virus. J Viral Hepat 14:817819.[CrossRef][PubMed]
186. Centers for Disease Control and Prevention (CDC). 2009. Laboratory-acquired vaccinia virus infection—Virginia, 2008. MMWR Morb Mortal Wkly Rep 58:797800.[PubMed]
187. Health and Safety Executive. 2003. Incidents—Lessons to be learnt. Accidental infection with vaccinia virus. http://www.hse.gov.uk/biosafety/gmo/acgm/acgm32/paper8.htm.
188. Korioth-Schmitz B, Affeln D, Simon SL, Decaneas WM, Schweon GB, Wong M, Gardner A. 2015. Vaccinia virus—laboratory tool with a risk of laboratory-acquired infection. Appl Biosaf 20:611.[CrossRef]
189. Marennnikova SS, Zhukova OA, Manenkova GM, Ianova NN. 1988. [Laboratory-confirmed case of human infection with ratpox (cowpox)]. Zh Mikrobiol Epidemiol Immunobiol 6:3032.[PubMed]
190. McCollum AM, Austin C, Nawrocki J, Howland J, Pryde J, Vaid A, Holmes D, Weil MR, Li Y, Wilkins K, Zhao H, Smith SK, Karem K, Reynolds MG, Damon IK. 2012. Investigation of the first laboratory-acquired human cowpox virus infection in the United States. J Infect Dis 206:6368.[CrossRef][PubMed]
191. Venter M, Steyl J, Human S, Weyer J, Zaayman D, Blumberg L, Leman PA, Paweska J, Swanepoel R. 2010. Transmission of West Nile virus during horse autopsy. Emerg Infect Dis 16:573575.[CrossRef][PubMed]
192. Weissenbacher MC, Cura E, Segura EL, Hortal M, Baek LJ, Chu YK, Lee HW. 1996. Serological evidence of human hantavirus infection in Argentina, Bolivia and Uruguay. Medicina (B Aires) 56:1722.[PubMed]
193. Desmyter J, Johnson KM, Deckers C, Leduc JW, Brasseur F, Van Ypersele De Strihou C. 1983. Laboratory rat associated outbreak of haemorrhagic fever with renal syndrome due to Hantaan-like virus in Belgium. Lancet 332:14451448.[CrossRef][PubMed]
194. Wang GD. 1985. [Outbreak of hemorrhagic fever with renal syndrome caused by a laboratory animal (white rat) infection]. Zhonghua Liu Xing Bing Xue Za Zhi 6:233235.[PubMed]
195. Zhang YZ, Dong X, Li X, Ma C, Xiong HP, Yan GJ, Gao N, Jiang DM, Li MH, Li LP, Zou Y, Plyusnin A. 2009. Seoul virus and hantavirus disease, Shenyang, People's Republic of China. Emerg Infect Dis 15:200206.[CrossRef][PubMed]
196. Zhang Y, Zhang H, Dong X, Yuan J, Zhang H, Yang X, Zhou P, Ge X, Li Y, Wang LF, Shi Z. 2010. Hantavirus outbreak associated with laboratory rats in Yunnan, China. Infect Genet Evol